No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CAMT Camtek
- 82.160
- +3.300+4.18%
Close Apr 26 16:00 ET
- 82.600
- +0.440+0.54%
Post 18:51 ET
3.71BMarket Cap50.40P/E (TTM)
83.350High80.360Low256.86KVolume80.730Open78.860Pre Close21.15MTurnover0.96%Turnover Ratio50.40P/E (Static)45.13MShares89.07552wk High7.79P/B2.19BFloat Cap25.28452wk Low--Dividend TTM26.64MShs Float89.075Historical High--Div YieldTTM3.79%Amplitude0.190Historical Low82.329Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Royce Micro-Cap Trust (NYSE: RMT) as of Mar 31, 2024
NEW YORK, April 26, 2024 /PRNewswire/ -- Average weekly trading volume of approximately 538,245 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING
The Total Return for Camtek (NASDAQ:CAMT) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
Camtek TO REPORT FIRST QUARTER 2024 FINANCIAL Results ON MAY 9, 2024
Express News | Shares of Semiconductor and Chip Stocks Are Trading Lower. The Sector Has Been Under Pressure This Week Following Earnings From ASML and TSMC. Stocks Have Been Mixed Friday Amid Overall Market Uncertainty on Iran-Israel Tensions
Top Midday Gainers
Intra-Cellular Therapies (ITCI) shares were more than 24% higher Tuesday after reporting topline results showing a combination of its Caplyta schizophrenia medication with an antidepressant resulted in a clinically significant reduction in symptoms of major depressive disorder.
Express News | Camtek Shares Are Trading Higher After Evercore ISI Group Initiated Coverage on the Stock With an Outperform Rating and $100 Price Target
Comments
Camtek's positive outlook seems priced in, with shares trading above industry multiples. Despite encouraging earnings prospects, the high PE ratio suggests limited upside from mispricing. Potential investors might await a price drop before buying.
What Is Camtek Ltd.'s (NASDAQ:CAMT) Share Price Doing?Camtek's CEO, Rafi Amit, attributes the record Q4 to high demand for high performance computing (HPC) and anticipates 2024 to be a record year for Camtek, even without the contribution of FRT to the results.
1
Camtek Ltd.'s high P/E ratio is alarming considering its below-market projected growth. Investors expecting a business upturn may be let down if the P/E aligns with the growth forecast. The share price might drop unless conditions notably enhance.
1
Despite Camtek's reinvestment, the decreasing ROCE trend is concerning. The market's optimism, reflected in a 1,042% return to long-term shareholders, may be misplaced if these trends persist.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg